These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 7796503)

  • 1. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes.
    Chadwick IG; O'Toole L; Morice AH; Yeo WW; Jackson PR; Ramsay LE
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):485-9. PubMed ID: 9156358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype.
    Velloso EP; Vieira R; Cabral AC; Kalapothakis E; Santos RA
    Braz J Med Biol Res; 2007 Apr; 40(4):583-90. PubMed ID: 17401503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme.
    Ueda S; Elliott HL; Morton JJ; Connell JM
    Hypertension; 1995 Jun; 25(6):1266-9. PubMed ID: 7768572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
    Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population.
    Paillard F; Chansel D; Brand E; Benetos A; Thomas F; Czekalski S; Ardaillou R; Soubrier F
    Hypertension; 1999 Sep; 34(3):423-9. PubMed ID: 10489388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
    Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I
    Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus.
    Luik PT; Hoogenberg K; Kerstens MN; Beusekamp BJ; De Jong PE; Dullaart RP; Navis GJ
    Diabetologia; 2003 Aug; 46(8):1131-9. PubMed ID: 12856080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
    De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK
    Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crises.
    Hirschl MM; Binder M; Bur A; Herkner H; Woisetschläger C; Bieglmayer C; Laggner AN
    J Hum Hypertens; 1997 Mar; 11(3):177-83. PubMed ID: 9175570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
    Hisatake S; Kiuchi S; Kabuki T; Oka T; Dobashi S; Ikeda T
    Heart Vessels; 2017 Mar; 32(3):303-308. PubMed ID: 27421979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels.
    Danser AH; Derkx FH; Hense HW; Jeunemaître X; Riegger GA; Schunkert H
    J Hypertens; 1998 Dec; 16(12 Pt 2):1879-83. PubMed ID: 9886872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gender on the renal response to angiotensin II.
    Miller JA; Anacta LA; Cattran DC
    Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentration of renin-angiotensin system components in association with ACE I/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy.
    Hristova M; Stanilova S; Miteva L
    Clin Exp Hypertens; 2019; 41(7):662-669. PubMed ID: 30307755
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production.
    Azizi M; Junot C; Ezan E; Hallouin MC; Guyene T; Ménard J
    J Mol Med (Berl); 2002 Aug; 80(8):492-8. PubMed ID: 12185449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.